<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0580">
 <element-citation publication-type="journal" id="rf0580">
  <person-group person-group-type="author">
   <name>
    <surname>Tanaka</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kamiyama</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Daikoku</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Nomura</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kurokawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Shiraki</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>T-705 (Favipiravir) suppresses tumor necrosis factor alpha production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug</article-title>
  <source>
   <italic>Acta Virologica</italic>
  </source>
  <volume>61</volume>
  <year>2017</year>
  <fpage>48</fpage>
  <lpage>55</lpage>
  <pub-id pub-id-type="pmid">28105854</pub-id>
 </element-citation>
</ref>
